Abstract
Background
Preeclampsia is a heterogeneous disorder prevalent in 3–10% of pregnant women globally. The etiology is multifactorial. There is a initial stage of endothelial dysfunction and placental ischemia (Stage 1); this leads to maternal syndrome of hypertension, edema, and proteinuria (Stage 2). Drugs acting on immunomodulatory, anti-inflammatory, antioxidant and proresolving pathways can minimize the complications of preeclampsia. The therapeutic effect of aspirin is based on acetyl group and salicylate group. Both components have independent therapeutic effects on anti-inflammatory pathway and proresolving pathway.
Aims and Objectives
This study was designed to assess the effectiveness and safety of aspirin in prevention and treatment of symptoms and complications of preeclampsia in women at high risk of preeclampsia.
Methods
This is a prospective experimental study to evaluate the effectiveness of aspirin versus placebo in the prevention of maternal syndrome of preeclampsia in women with high risk of preeclampsia (G1 = 97, G2 = 92). Patients with age ≥ 34, chronic hypertension, multiple pregnancies, gestational diabetes, and high pulsatility index of uterine artery were enrolled between 12 and 20 weeks of gestation and prescribed 75 mg aspirin daily till 34 weeks of gestation. Control group was not prescribed aspirin.
Observations and Results
There was a reduction in relative risk of preeclampsia in aspirin group as compared with control group. There was no significant increase in the number of cases of abruption placenta, preterm delivery, neonatal intraventricular hemorrhage, patent ductus arteriosus, and postpartum hemorrhage following aspirin therapy.
Conclusion
In patients with high mean pulsatility index of uterine arteries, low dose aspirin can be a useful intervention. Uterine artery Doppler is a simple and noninvasive test which can be used safely for the prediction of preeclampsia. Aspirin is safe, economical, and easily available commercially.
Similar content being viewed by others
References
Adu Bonsaffoh K, Samuel OA, Binlinha G. Maternal death attributable to hypertensive disorders in tertiary hospital in Ghana. Int J Gynaecol Obstet. 2013;123:110–3.
Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of preeclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynecol. 2011;25:391–403.
Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376(9741):631–44.
Roberts JM, Hubel CA. The two-stage model of preeclampsia: variations on the theme. Placenta. 2009;30(Supple A):S32–7.
Ahmed A, Ramma W. Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm? Br J Pharmacol. 2015;172(6):1574–86.
Bujold E, Roberge S, Lacasse Y, Bureau M, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta analysis. Obstet Gynaecol. 2010;116(2):402–14.
Schrör K. Acetylsalicylic acid. Weinheim: Wiley; 2010.
Alverez AM, Mulla MJ, Chamely LW, Cadavid AP, et al. Aspirin triggered lipoxins prevents antiphospholipid antibody effects on human trophoblast migration and endothelial cell interactions. Arthritis Rheumatolol. 2015;67(2):488–97.
Madariaga-Venegas F, Fernández-Soto R, Duarte LF, Suarez N, et al. Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients. PLoS ONE. 2017;12(5):e0176755. doi:10.1371/journal.pone.0176755.
Lausman A, Kingdom J, Bradley T. Subclinical atherosclerosis in association with elevated placental vascular resistance in early pregnancy. Atherosclerosis. 2009;. doi:10.1016/j.atherosclerosis.2009.02.007.
Llurba E, Carreras E, Gratacós E, et al. Maternal history and uterine artery Doppler in the assessment of risk for development of early- and late-onset preeclampsia and intrauterine growth restriction. Obstet Gynecol Int. 2009;. doi:10.1155/2009/275613.
Everett TR, Mahendru AA, McEniery CM, Wilkinson IB, et al. Raised uterine artery impedance is associated with increased maternal arterial stiffness in the late second trimester. Placenta. 2012;33(7):572–7. doi:10.1016/j.placenta.2012.04.001.
Khan F, Mires G, Macleod M, et al. Relationship between maternal arterial wave reflection, micro vascular function and fetal growth in normal pregnancy. Microcirculation. 2010;17:608e.
Enkhmaa D, Wall D, Mehta PK, Stuart JJ, et al. Preeclampsia and vascular function: a window to future cardiovascular disease risk. J Women’s Health. 2016;. doi:10.1089/jwh.2015.5414.
Cadavid AP. Aspirin: the mechanism of action revisited in the context of pregnancy complications. Front Immunol. 2017;8:261. doi:10.3389/fimmu.2017.00261.
Papageorghiou AT, Yu CK, Bindra R, Pandis G, et al. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol. 2001;18(5):441–9. doi:10.1046/j.0960-7692.2001.00572.x.
Cnossen J, Morris R, Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178:701–11.
Serhan CN. Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators. J Periodontol. 2008;79(8 Suppl):1520–6. doi:10.1902/jop.2008.080231.
Gil Villa AM, Norling LV, Serhan CN, Cordero D, et al. Aspirin triggered Lipoxin A 4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma. Prostaglandins Leukot Essential Fatty Acids. 2012;87(4–5):127–34.
Dalli J, Winkler JW, Colas RA, Arnardottir H, et al. Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem Biol. 2013;20(2):188–201. doi:10.1016/j.chembiol.2012.11.010.
Romano M. Lipoxin and aspirin-triggered lipoxins. Sci World J. 2010;2(10):1048–64. doi:10.1100/tsw.2010.113.
Maderna P, Godson C. Lipoxins: resolutionary road. Br J Pharmacol. 2009;158(4):947–59. doi:10.1111/j.1476-5381.2009.00386.x.
Atarod Z, Kiani LA, Hashemi SA, et al. Effects of low dose aspirin in the prevention of preeclampsia in pregnant women with abnormal uterine artery Doppler at 11-14 weeks of gestation. Med J Obstet Gynecol. 2015;3(5):1068.
Cantu JA, Jauk VR, Owen J, Biggio JR, et al. Is low-dose aspirin therapy to prevent preeclampsia more efficacious in non-obese women or when initiated early in pregnancy? J Matern Fetal Neonatal Med. 2015;28(10):1128–32. doi:10.3109/14767058.2014.947258.
Meher S, Alfirevic Z. Aspirin for pre-eclampsia: beware of subgroup meta-analysis. Ultrasound Obstet Gynecol. 2013;41:479–85. doi:10.1002/uog.12470.
Scifres CM, Iams JD, Klebanoff M, et al. Metaanalysis vs large clinical trials: which should guide our management? Am J Obstet Gynecol. 2009;200(484):e1–5.
Thornton J. Commentary on aspirin for prevention of preeclampsia in high-risk women. BJOG. 2013;120:74–5.
Villa P, Kajantie E, Räikkönen K, et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG. 2013;120:64–74.
Bujold E, Roberge S, Lacasse Y, Bureau M, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402–14.
Bujold E, Morency AM, Roberge S, Lacasse Y, et al. Gigue`re Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2009;31:818–26.
Roberge S, Villa P, Nicolaides K, et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31:141–6.
America College of Obstetrician and Gynecologist. Task force on hypertension in pregnancy. Report of the American college of Obstetrician and gynecologist’s task force on Hypertension in pregnancy. Obstet Gynaecol. 2013;122(5):1122–31.
Mone F, Mulachy C, Mcparland P, et al. Should we recommend universal aspirin for all pregnant women? Am J Obstet Gynaecol. 2017;216(2):141e1–5.
Schisterman EF, Silver RM, Lesher LL, et al. Preconceptional low dose aspirin and pregnancy outcomes: results from EAGeR randomized trial. Lancet. 2014;384(9937):29–36.
Acknowledgements
We thank our staff and Obstetrics and Gynecology outpatient staff for helping in the care given to the patients.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest. We do not have any commercial association that might pose a conflict of interest in connection with the manuscript. We certify that neither this manuscript nor one with substantially similar content under our authorship has been published or is being considered for publication elsewhere.
Ethical Clearance
Ethical Committee approval was obtained from the Institutional Research Board.
Informed Consent
The research participants were informed about the study in local language and informed written consent was taken after explaining the nature of ultrasound Doppler scan in pregnancy. We have obtained the patient’s consent for participation in research. Ethical committee clearance and research board clearance was obtained for this study according to the Principle of Helsinki.
Additional information
Nidhi Sharma, Professor, in the Department of Obstetrics and Gynecology, Saveetha Medical College, Saveetha University, Chennai, India; Sunayana Srinivasan, Senior Resident, in the Good Samaritan Medical Centre, West Islip, New York, USA; K. Jayashree Srinivasan, Professor and Head of the Department, in the Department of Obstetrics and Gynecology, Saveetha Medical College, Saveetha University, Chennai, India; Kulasekaran Nadhamuni, Professor and Head of the Department, in the Department of Obstetrics and Gynecology, Saveetha Medical College, Saveetha University, Chennai, India.
Rights and permissions
About this article
Cite this article
Sharma, N., Srinivasan, S., Srinivasan, K.J. et al. Role of Aspirin in High Pulsatility Index of Uterine Artery: A Consort Study. J Obstet Gynecol India 68, 382–388 (2018). https://doi.org/10.1007/s13224-017-1058-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-017-1058-4